Vidi još

Literatura

1. ^Skuza G, Rogóz Z (2006). „The synergistic effect of selective sigma receptor agonists and uncompetitive NMDA receptor antagonists in the forced swim test in rats”.J. Physiol. Pharmacol.57 (2): 217—29.PMID 16845227. 
2. ^Cassano G; Gasparre G; Contino M; et al. (2006). „The sigma-2 receptor agonist PB28 inhibits calcium release from the endoplasmic reticulum of SK-N-SH neuroblastoma cells”.Cell Calcium.40 (1): 23—8.PMID 16687172.doi:10.1016/j.ceca.2006.03.004. CS1 одржавање: Експлицитна употреба et al. (веза)
3. ^Bowen WD (2000). „Sigma receptors: recent advances and new clinical potentials”.Pharm Acta Helv.74 (2–3): 211—8.PMID 10812960.doi:10.1016/S0031-6865(99)00034-5. 
4. ^Laurini E, Zampieri D, Mamolo MG, Vio L, Zanette C, Florio C, Posocco P, Fermeglia M, Pricl S (2010). „A 3D-pharmacophore model for sigma2 receptors based on a series of substituted benzo[d]oxazol-2(3H)-one derivatives”.Bioorg. Med. Chem. Lett.20 (9): 2954—7.PMID 20347592.doi:10.1016/j.bmcl.2010.03.009. 

Spoljašnje veze